🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,413 results for “ACE” Clear

  1. Baritinib

    The First People's Hospital of Lianyungang

    Intracerebral Hemorrhage

    phase 2 small molecule completed

    1 trial

  2. Baxdrostat, Dapagliflozin Placebo, Forxiga 10 mg film-coated tablets

    AstraZeneca AB

    Chronic kidney disease (CKD) and hypertension.

    phase 2 small molecule active

    1 trial

  3. Bemnifosbuvir

    Atea Pharmaceuticals

    Chronic Hepatitis C Virus

    phase 2 small molecule completed

    1 trial

  4. Benlysta 200 mg solution for injection in pre-filled syringe., Placebo of belimumab

    Pari Pharma GmbH

    Cryoglobulinemia vasculitis

    phase 2 small molecule active

    1 trial

  5. Bepranemab, Placebo matching and without active substance, Neuraceq 300 MBq/mL solution for injection, (18F) GTP1

    Lacuna Pharma Pty Ltd

    Alzheimer’s Disease

    phase 2 small molecule active

    1 trial

  6. Berubicin

    CNS Pharmaceuticals

    Glioblastoma Multiforme, Adult

    phase 2 small molecule active

    1 trial

  7. Berubicin hydrochloride, Cecenu® 40 mg Kapsel

    CNS Pharmaceuticals

    Glioblastoma multiforme (GBM)

    phase 2 small molecule active

    1 trial

  8. Bexarotene

    LIGAND PHARMACEUTICALS INC

    Sarcoma, Kaposi

    phase 2 small molecule completed

    1 trial

  9. Bexarotene

    LIGAND PHARMACEUTICALS INC

    Lung Cancer

    phase 2 small molecule completed

    1 trial

  10. Bexarotene (targretin)

    LIGAND PHARMACEUTICALS INC

    Carcinoma, Non-small-cell Lung

    phase 2 small molecule terminated

    1 trial

  11. Bexarotene 1% gel

    LIGAND PHARMACEUTICALS INC

    Parapsoriasis

    phase 2 small molecule terminated

    1 trial

  12. Bexarotene/NBUVB vs placebo NBUVB

    LIGAND PHARMACEUTICALS INC

    Psoriasis

    phase 2 small molecule completed

    1 trial

  13. Bicarbonate de sodium

    Jazz Pharmaceuticals Ireland Limited

    Hematologic Disease

    phase 2 small molecule completed

    1 trial

  14. Bicifadine

    XTL BIOPHARMACEUTICALS LTD

    Diabetic Peripheral Neuropathy

    phase 2 small molecule active

    1 trial

  15. Bicifadine

    XTL BIOPHARMACEUTICALS LTD

    Chronic Peripheral Neuropathy Pain in Diabetics

    phase 2 small molecule terminated

    1 trial

  16. Bion 1301/FUB523

    Novartis Pharmaceuticals

    IgA nephropathy

    phase 2 small molecule active

    1 trial

  17. Bivalent killed oral cholera vaccine

    International Peace Maternity and Child Health Hospital

    Cholera

    phase 2 mab active

    1 trial

  18. Bivamelagon

    Rhythm Pharmaceuticals Netherlands B.V.

    Hypothalamic Obesity

    phase 2 small molecule active

    1 trial

  19. Botulinum Toxin Type B (Myobloc)

    SUPERNUS PHARMACEUTICALS, INC.

    Drooling

    phase 2 mab completed

    1 trial

  20. Brenipatide, Brenipatide, Brenipatide, Brenipatide, Placebo to match LY

    Eli Lilly Co.

    Asthma

    phase 2 small molecule active

    1 trial

  21. Brexanolone

    SUPERNUS PHARMACEUTICALS, INC.

    Tinnitus

    phase 2 small molecule completed

    1 trial

  22. Brimo PS DDS®

    Allergan Pharmaceuticals International Limited

    Patients Who Participated in an Intravitreal Brimo PS DDS® Study

    phase 2 small molecule completed

    1 trial

  23. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Adenovirus Disease

    phase 2 small molecule completed

    1 trial

  24. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Cytomegalovirus Infection

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources